Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Noncoding RNA Lipotherapeutics: A Promising Breakthrough in Pulmonary Hypertension Treatment

2 Apr 2024

Abstract excerpt

Pulmonary Hypertension (PH) is a complex cardiovascular disorder characterized by elevated blood pressure in the pulmonary arteries. Current therapeutic approaches for PH have limitations in addressing the underlying molecular mechanisms. This article explores the potential of noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), delivered through...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Circular RNAs in diseases
Share to Pulmonary Hypertension Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38561610
DOI: 10.2174/0113892010302590240321073509

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Noncoding RNA Lipotherapeutics: A Promising Breakthrough in Pulmonary Hypertension TreatmentPMID 38561610Read ↗

Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanismSemantic proximity Read ↗

RNA therapeutics for cardiovascular diseaseSemantic proximity Read ↗

Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosisSemantic proximity Read ↗

Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeuticsSemantic proximity Read ↗

Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical TargetsSemantic proximity Read ↗

Unlocking the potential of RNA-based therapeutics in the lung: current status and future directionsSemantic proximity Read ↗

Advances in RNA Therapeutics: Classes, Innovations and Clinical ApplicationsSemantic proximity Read ↗

Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imagingSemantic proximity Read ↗

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsSemantic proximity Read ↗

Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editingSemantic proximity Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

Regulation of circular RNAs act as ceRNA in a hypoxic pulmonary hypertension rat modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.